The following table shows the list of Horizon 2020 projects developed by "IPSEN INNOVATION SAS". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 936 |
| 2 | eTRANSAFE | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 1110 |
| totale | 0.00 | |||||
This organization collaborated with partners in 14 countries.
Within the project ADAPT-SMART this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
| participant | UK | AbbVie | AbbVie Ltd (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
| participant | FR | Lysogene | LYSOGENE (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
| participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
| participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
| participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
| participant | BE | Amgen | AMGEN (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
| coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project eTRANSAFE this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | JP | Eisai | EISAI CO LTD (PRC) |
| participant | UK | Clarivate | CLARIVATE ANALYTICS (UK) LIMITED (PRC) |
| participant | UK | PDS | PDS COMPUTER SOFTWARE LIMITED (PRC) |
| participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | US | AbbVie | ABBVIE INC (PRC) |
| participant | UK | OPTIBRIUM | OPTIBRIUM LIMITED (PRC) |
| participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | UK | LL | LHASA LIMITED (REC) |
| participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
| participant | DE | MN | MOLECULAR NETWORKS GMBH COMPUTERCHEMIE (PRC) |
| participant | UK | LJMU | LIVERPOOL JOHN MOORES UNIVERSITY (HES) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
| coordinator | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
| participant | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
| participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
| participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
| participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |